FDA approves cure for sickle cell disease, the first treatment to use gene-editing tool CRISPR
The Food and Drug Administration granted approval for a potent treatment for sickle cell disease, an incurable ailment that impacts over 100,000 Americans, with a disproportionately African American population. Casgevy, a treatment developed in collaboration with CRISPR Therapeutics and Vertex Pharmaceuticals, is the inaugural pharmaceutical product to receive approval in the United States that employs … Read more